{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:59Z","timestamp":1787026319888,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Cardiac involvement is the main prognostic determinant in AL amyloidosis. We sought to determine the prognostic significance of longitudinal change of left ventricular (LV) global longitudinal strain (GLS) in cardiac light chain (AL) amyloidosis patients undergoing chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Result<\/jats:title>\n                    <jats:p>We retrospectively investigated 117 cardiac AL amyloidosis patients who underwent chemotherapy from 2005 to 2019. All patients underwent comprehensive 2D conventional transthoracic echocardiography at baseline and after completion of first-line chemotherapy. Speckle tracking analysis of images was performed offline. Absolute value of LV GLS was expressed as [LV GLS] and change of [LV GLS] after chemotherapy was expressed as \u0394 [LV GLS]. Clinical outcomes including cardiac response and all-cause mortality were analyzed.<\/jats:p>\n                    <jats:p>\n                      Baseline clinical and echocardiographic parameters were similar in patients with and without CR. \u0394 [LV GLS] significantly differed between the CR and non-CR groups (0.4 \u00b1 2.8% in the CR group vs. \u22120.6 \u00b1 2.5% in the non-CR group,\n                      <jats:italic>P<\/jats:italic>\n                      -value = 0.046). \u0394 [LV GLS] showed satisfactory predictive performance for all-cause mortality (cut-off value = 0.8%, AUC 0.643, 95% CI [0.537\u20130.748]). Adding \u0394 [LV GLS] to the Mayo stage + pre-chemotherapy [LV GLS] model showed incremental prognostic value (C-index: 0.637 vs. 0.708; Relative Integrated Discrimination Index 0.07,\n                      <jats:italic>P<\/jats:italic>\n                      -value = 0.003; Net Reclassification Improvement 0.54,\n                      <jats:italic>P-<\/jats:italic>\n                      value &amp;lt; 0.001). \u0394 [LV GLS] showed good correlation with cardiac response (AUC 0.820, 95% CI [0.737\u20130.904]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In cardiac amyloidosis patients who underwent chemotherapy, longitudinal change of [LV GLS] after chemotherapy showed significant association with overall survival as well as cardiac response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2022.904878","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:47:46Z","timestamp":1656031666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Minjung","family":"Bak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Oh","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1200\/JCO.20.01285","article-title":"Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis.","volume":"38","author":"Kastritis","year":"2020","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood.2019000834","article-title":"A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.","volume":"134","author":"Manwani","year":"2019","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.36628\/ijhf.2020.0016","article-title":"Untangling amyloidosis: recent advances in cardiac amyloidosis.","volume":"2","author":"Kim","year":"2020","journal-title":"Int J Heart Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1182\/blood-2009-11-253237","article-title":"Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement.","volume":"116","author":"Dietrich","year":"2010","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2141.2008.07327.x","article-title":"Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone.","volume":"143","author":"Lebovic","year":"2008","journal-title":"Br J Haematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/bjh.12191","article-title":"Light chain amyloidosis 2012: a new era.","volume":"160","author":"Gatt","year":"2013","journal-title":"Br J Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1002\/ajh.23936","article-title":"Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.","volume":"90","author":"Kastritis","year":"2015","journal-title":"Am J Hematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1182\/blood-2013-01-453001","article-title":"Systemic light chain amyloidosis: an update for treating physicians.","volume":"121","author":"Merlini","year":"2013","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.echo.2017.08.017","article-title":"Prognostic and added value of two-dimensional global longitudinal strain for prediction of survival in patients with light chain amyloidosis undergoing autologous hematopoietic cell transplantation.","volume":"31","author":"Pun","year":"2018","journal-title":"J Am Soc Echocardiog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.1038\/s41598-019-44245-9","article-title":"Associations of electrocardiographic parameters with left ventricular longitudinal strain and prognosis in cardiac light chain amyloidosis.","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.echo.2016.09.003","article-title":"Anterior aortic plane systolic excursion: a novel indicator of transplant-free survival in systemic light-chain amyloidosis.","volume":"29","author":"Ochs","year":"2016","journal-title":"J Am Soc Echocardiog."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.","volume":"60","author":"Buss","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain Doppler imaging in light-chain amyloidosis.","volume":"3","author":"Koyama","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis.","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/13506129.2019.1582486","article-title":"Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria.","volume":"26","author":"Muchtar","year":"2019","journal-title":"Amyloid."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1038\/s41598-019-48513-6","article-title":"Prognostic values of novel biomarkers in patients with AL amyloidosis.","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1200\/JCO.2013.48.7736","article-title":"New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.","volume":"31","author":"Girnius","year":"2013","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European association of cardiovascular imaging.","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiog."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11886-019-1094-z","article-title":"Echocardiographic findings in cardiac amyloidosis: inside two-dimensional, doppler, and strain imaging.","volume":"21","author":"Di Nunzio","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.","volume":"15","author":"Di Bella","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e002954","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study.","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","article-title":"Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of amyloid deposits.","volume":"12","author":"Bravo","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cardfail.2008.05.002","article-title":"Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.","volume":"14","author":"Krittayaphong","year":"2008","journal-title":"J Card Fail."},{"key":"B29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/01.cir.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation."},{"key":"B30","first-page":"391","article-title":"Doppler echocardiographic assessments of left ventricular diastolic filling in patients with amyloid heart disease.","volume":"21","author":"Hongo","year":"1991","journal-title":"J Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0735-1097(90)90545-z","article-title":"Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis.","volume":"16","author":"Klein","year":"1990","journal-title":"J Am Coll Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/eurjhf\/hfs107","article-title":"Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.","volume":"14","author":"Ersb\u00f8ll","year":"2012","journal-title":"Eur J Heart Fail."},{"key":"B33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCIMAGING.109.910893","article-title":"Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients.","volume":"3","author":"Nahum","year":"2010","journal-title":"Circ Cardiovasc Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.jacc.2012.07.047","article-title":"Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.","volume":"60","author":"Motoki","year":"2012","journal-title":"J Am Coll Cardiol."}],"updated-by":[{"DOI":"10.3389\/fcvm.2022.981833","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.904878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:00:56Z","timestamp":1658228456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.904878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2022.904878"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.904878","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"904878"}}